Category Archives: Stocks to Watch

U.S. Geothermal, Inc. (HTM) Investing in the Growing Future of Geothermal Energy

February 27, 2017

Safe and effective, geothermal energy has been used by mankind for over 10,000 years. Evidence shows that North American Paleo-Indians regularly used geothermal hot springs for warmth, cleansing and minerals. In the first century AD, Romans used geothermal energy to heat public baths and floors, and the world’s oldest geothermal district heating system has been operating since the 14th century in France. America’s first district heating system was powered directly by geothermal energy in 1892 in Boise, Idaho.

Geothermal heat energy is naturally produced by the Earth, originating from the natural radioactive decay of certain materials within the Earth’s crust. Temperature differences between the core of the planet and its surface drive a continuous conduction of thermal energy from the core to the surface.

After centuries of use for bathing and space heating, geothermal energy is now recognized for electricity production. Worldwide, 12,000 megawatts (MW) of geothermal power are currently online with 2,000 MW of installed capacity in the western United States. There’s also an additional 28 gigawatts of geothermal heating installed for space heating and multiple other applications around the world.

Geothermal power is cost-effective, reliable, sustainable, and environmentally friendly, but it has historically been limited to areas in the western U.S., where natural caldera formations occur. Population growth and technological advancements make geothermal energy production ever more appealing.

Calpine Corp (NYSE: CPN), Ormat Technologies (NYSE: ORA) and U.S. Geothermal (NYSE MKT: HTM) are recognized players in geothermal energy production. Of these, U.S. Geothermal is the largest pure play geothermal independent power producer. The company currently produces 45 MW from three existing assets in Oregon, Nevada, and Idaho. U.S. Geothermal also has four advanced development properties in California, Guatemala, and Nevada, with 90 MW capacity in their pipeline, plus four more early-stage properties in development.

Geothermal provides base load power 24/7 without interruption, is clean and renewable without significant output deterioration, and is not subject to the vagaries of commodity fuel prices. Publically-traded geothermal energy companies, such as U.S. Geothermal, now provide the opportunity to profit from our planet’s creation.

For more information, visit www.USGeothermal.com

Telkonet, Inc. (TKOI) Helps Organizations Decrease Operating Costs While Reducing Carbon Footprint

February 24, 2017

Since the recession in the mid-2000’s, the U.S. as a whole has made significant steps toward lowering its carbon emissions. In California, the California Energy Commission is the primary energy policy and planning agency, committed to helping individuals and organizations reduce their energy costs and environmental impact while maintaining a safe, reliable, and long-lasting supply of energy.

The standards outlined by California’s Energy Commission in Title 24 are updated every three years, aiming to improve upon the standards set in 2013, while continuing to reduce energy consumption and contribute toward reducing carbon dioxide emissions across the world. Two specific aspects of reducing carbon footprint are outlined in the standards, these include controlling space temperature and controlling lighting and plug loads.

Although the standards do not give clear recommendations on how to achieve the above, Telkonet, Inc. (OTCQB: TKOI), a company committed to sustainable product innovation and technological expertise, believes it has the answer. The company feels that implementing a single product able to work as an energy management system, with intelligent sensors and controllers that operate through a cloud-based command center, is far more efficient than using diverse products from numerous manufacturers.

With this in mind, Telkonet has developed EcoSmart, a revolutionary intelligent automation platform that works with a full suite of connected IoT (Internet Of Things) products and gives customers in-depth energy usage information, control, and analytics. The platform, made up of wireless devices, offers real-time reporting whereby it can track progress toward an individual’s or company’s energy efficiency goals.

Telkonet believes EcoSmart could be the solution to Title 24 compliance, as it is an all-in-one platform that allows clients to achieve a perfect balance between energy efficiency and occupant comfort. The EcoSmart system decreases energy usage in unoccupied spaces so that it doesn’t affect tenants living or working in the space. The solution is perfect for unpredictable spaces, such as hotels, university residences, offices, and others.

For more information, visit www.Telkonet.com

M Pharmaceutical, Inc. (MPHMF) Aims to Develop the Best-Selling Weight Loss Medication of All Time

There’s a growing obesity epidemic in the United States. Currently, almost 80 million people in the U.S. are obese, with two out of every three Americans considered to be either obese or overweight.

The obesity rate in 1990 was 12 percent, which nearly doubled to 23 percent in 2005. It increased to 35 percent by 2010 and now exceeds 38 percent. The Centers for Disease Control and Prevention has projected the U.S. obesity rate to exceed 42 percent by 2030.

This rampant increase persists while obesity remains one of the most significant drivers of preventable chronic diseases and health care costs in the United States. Estimates for obesity-related health care costs range from $147 billion to well over $200 billion annually.

This epidemic presents enormous opportunity for pharmaceutical companies targeting obesity. Analysts estimate that the worldwide market for obesity drugs, devices, and surgical procedures totals hundreds of billions of dollars. Novo Nordisk (NYSE: NVO) introduced Saxenda, its first medical treatment for obesity, to the market over a year ago. Results have been promising, but Saxenda is expensive and requires patient injections. Vivus (NASDAQ: VVUS) and Arena (NASDAQ: ARNA) both introduced weight loss drugs designed with the intention of aiding obese people with a BMI of 30 or higher. Neither of these drugs has captured attention or market share like orlistat.

Orlistat, the best-selling weight loss medication of all time, is marketed in different formats by Roche (OTCQX: RHHBY) and GlaxoSmithKline (NYSE: GSK). Orlistat has proven safe and effective in over 100 clinical trials, however, orlistat produces unpleasant gastrointestinal effects that have led to significant sales declines.

Less than a year ago, M Pharmaceutical, Inc. (OTCQB: MPHMF) acquired exclusive rights to a reformulation of orlistat, the obesity drug C-103, in both prescription strength and over-the-counter formulations. With three patient studies completed, M Pharmaceutical’s reformulation of orlistat was shown to eliminate the adverse effects in 98 percent of trial patients.

With patent protection in 131 countries through 2030, M Pharmaceutical has global designs for its reformulation of orlistat and may exceed current orlistat to become the best-selling weight loss medication of all time.

For more information, visit www.M-Pharma.ca

The Alkaline Water Co. (WTER) Reports Revenue Jump of 78% for Nine Months Ended December 31, 2016

February 23, 2017

Expanded distribution to 36 more of the top national grocery retailers propelled The Alkaline Water Company, Inc. (OTCQB: WTER) to reach revenues of $8,927,976 for the nine months ended December 31, 2016. This represents an increase of 78% compared to $5,010,547 generated during the same period in 2015. For its third quarter ended December 31, 2016, sales were $2,973,689, a 67% increase from its sales of $1,777,701 for the same period in 2015. The company is in the bottled water industry. Its fiscal year ends March 31.

For both periods, the company sharply cut its losses. For the three months ended December 31, 2016, the net loss was $498,374, compared to its loss of $1,094,721 during the same period in 2015. For the nine months ended December 31, 2016, the net loss was $2,787,681, compared to the net loss of $3,644,028 during the same period in 2015.

In its February 14, 2017, SEC 10-Q filing (http://dtn.fm/aHu7g), The Alkaline Water Company, Inc., stated that its jump in revenues for the three and nine months ended December 31, 2016, was attributed to the increase in its distribution. In both 2016 and 2015 periods ending on December 31, the company’s products were available in all 50 states. However, for the year ended March 31, 2016, its water products were in 25,000 retail locations instead of just 20,000 the prior year. That increased distribution, the company reported to the SEC, generated the increased revenues for the most recent three- and nine-month periods ended December 31, 2016.

In the SEC filing, the company said that it sells to customers including the food chains of Albertson’s, Safeway, Kroger, Jewel-Osco and more. It also sells to convenience stores and natural foods product stores, the filing stated. It sold direct to large national distributors. In both the three-month and nine-month periods ended December 31, 2016, the company’s increased volume meant that its gross profit rate increased, as it was able to buy raw materials in larger volume from its suppliers. As a result, its losses for both the three months and nine months ended December 31, 2016, were reduced.

In the 10-Q, The Alkaline Water Company, Inc., reported that it had entered, on February 1, 2017, a $3 million, three-year, revolving credit agreement with SCM Specialty Finance Opportunities Fund, L.P. It has drawn $686,080.94 on that financial revolver to pay off the amount it borrowed earlier from Gibraltar Business Capital, LLC. Of the total, $628,782.94 was used to pay off the Gibraltar debt, and the remaining monies paid closing costs.

For more information, visit www.TheAlkalineWaterCo.com

Golden Entertainment, Inc. (NASDAQ: GDEN) Set to Capitalize on the Immensity of the US Gambling Market

Billions of dollars are generated from the U.S. gambling market each year. Despite a new movement toward online gambling, especially in the United Kingdom, physical brick and mortar casinos are still dominating in terms of revenue.

A political aspect that could impact the casino industry in the U.S. is the election of Donald Trump. Although moral issues still surround the market, the new president has close affiliations with the casino industry. In 2015, gross gaming revenue (GGR) came in at over 40%, but in 2016, according to CasinoNewsDaily.com (http://dtn.fm/r1Qjq), the U.S. was at the top of the full-year losses chart, the number representing the amount staked by gambling customers minus payouts.

According to InvestmentWatchBlog.com (http://dtn.fm/Qfro6), the casino annual growth rate in Nevada came in at 4.5% between 2011 and 2015, with a market growth during that period of 7.3%. Despite it not being known how much revenue makes up the online casino industry compared to the brick and mortar casino industry, slots make up 50% of gaming revenue in Nevada.

Golden Entertainment, Inc. (NASDAQ: GDEN), the largest branded tavern operator in Nevada and a market leader in distributed gaming, is set to capitalize on the immensity of the U.S. gambling market through its robust development and acquisition pipeline, which included the acquisitions of C. Lohman Games, Inc. in January 2016, and Amusement Services, LLC in April of the same year. The company now has over 10,000 devices in over 1,000 locations across the United States, including Pahrump Nugget Hotel & Casino, Gold Town Casino, and Lakeside Casino & RV Park, all of which are in Nevada.

Golden Entertainment has multiple paths to achieve meaningful growth. For 2017, the company has seven new taverns under development with a robust pipeline of new-build sites. The company plans to acquire smaller distributed gaming operators that lack the scale to compete in profitability, as well as regional casino assets, and also to reinvest in existing casino properties, such as its Rocky Gap and Pahrump facilities.

Golden Entertainment currently owns rights to potential distributed gaming locations and aims to pioneer new distributed gaming jurisdictions across the country. Additionally, by merging with public gaming operators, the company is offering the potential for increased liquidity to shareholders.

For more information, visit www.GoldenEnt.com

Vertex Energy, Inc. (NASDAQ: VTNR) Enters into $30 Million Credit Refinancing

Vertex Energy, Inc. (NASDAQ: VTNR) announced on February 8, 2017, that it has reached an agreement with Encina Business Credit, LLC (EBC) for a $30 million credit refinancing, including a funded term note, a draw term loan, and a revolving line of credit. The company indicated that the funds will be used to retire debt and for working capital.

Vertex Energy, Inc., refines and markets high quality hydrocarbon products. It filed an 8-K with the SEC on February 7, 2017, defining the new credit facility from EBC.

“The refinance of the company’s prior credit facility reflects our belief in the future growth of the company,” said Benjamin P. Cowart, CEO of Vertex. “We believe that this step was necessary in ensuring that we clean up our balance sheet, which includes paying off both of our prior lenders, consolidating our debt into one facility and strengthening our cash position.”

EBC is an asset-based lender specializing in middle market borrowers. Its revolving lines of credit and term loans range from $5 million to $50 million. It lends to both public and private companies. Positive cash flow is not required.

Cowart added that Vertex Energy is positioned to grow its business in 2017.

“With the financing completed, we were able to close on the acquisition on the assets of a small collection company in Louisiana. With approximately 90 million gallons of processing capacity, we believe that our collections vertical is key to our growth,” he said.

The company anticipates growing its self-collected gallons from some 20% of overall production to 25% in 2017, he added.

The SEC 8-K filing detailed the arrangements with EBC. It stated that $12 million was loaned to Vertex by EBC on February 1, 2017, and an additional $8 million may be loaned from time to time, under the new credit agreement. The other $10 million will be made available by EBC to Vertex under a revolving credit agreement formula, including ‘eligible’ inventory. The revolving credit agreement terminates on February 1, 2020, when any unpaid amounts and interest are due, the filing states.

Vertex Energy, Inc. stated that its use of revolving credit funds would be for working capital, capital expenditures and to refinance existing credit obligations. The company used $11,282,537 for that purpose. As of the filing date, the company had borrowed $12 million of the EBC credit agreement and $884,000 under the revolving credit agreement.

For more information, refer to www.VertexEnergy.com

AudioEye, Inc. (AEYE) Adds 51 Banking Clients, Raises 2017 Bookings Goal

February 22, 2017

AudioEye, Inc. (OTCQB: AEYE) has 51 new banking customers this year, it announced on February 6, 2017 (http://dtn.fm/Sa5h3), giving it a total of 175 additional banking clients over the past 12-month period.

AudioEye, Inc. develops accessibility compliance software that enables its clients to use advanced technology to achieve greater accessibility. The result is that engineers are able to add accessibility into their websites.

Dan Sullivan, vice president of sales, pointed out that adding 51 new banking clients in the first 47 days of 2017 is more than one new client per day in this sector. “Risk mitigation continues to be the dominant driver in the increase of service agreements, but when our potential new customers realize accessibility opens up access and usability to a new population of users to upwards of 10%-15% of the population, they find a true return on investment (ROI) in our service.”

AudioEye, Inc. also announced, on February 6, 2017, its goal for 2017 cash contract advanced bookings was $4 million-$6 million, indicating that its new business pipeline is in excess of $5.4 million. Earlier, AudioEye reported cash contract sales for 2016 at $1.93 million. It said it was targeting governmental agencies, schools, banks, retail and human resources as markets that require accessible technologies.

AudioEye, Inc. has also been named vendor to Seattle Public Schools District 1 (http://dtn.fm/3tWVj) to ensure the web content, websites and pages are compliant and available. The vote to name AudioEye, Inc. was unanimous, the company announced on January 24, 2017. AudioEye, Inc. makes software designed to enable all entities, from corporations to governmental agencies, to make technology more easily consumable.

Seattle Public Schools (SPS) stated that the decision to choose AudioEye was made after an extensive vendor evaluation process to find a company that could solve a difficult problem economically.

In the news release, Sean Bradley, president and CTO of AudioEye, said, “With approximately 98 school locations, 8,000 staff and 54,000 students within the limits of Seattle, SPS is prioritizing digital inclusion as they seek to ensure an accessible user experience for all their constituents, regardless of individual ability.” The solution was located in AudioEye’s digital platform and managed services.

For more information, visit www.AudioEye.com

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) Files SEC Prospectus

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) on January 10, 2017, filed with the SEC a prospectus (http://dtn.fm/rU7Lh) for the sale in the aggregate of $33,842,512 of its common stock. The use of proceeds will be to fund both clinical and non-clinical studies of its product candidates and for general working capital.

Catalyst Pharmaceuticals is a development stage biopharmaceutical company which is developing CPP-115 to treat reduced GABAergic signaling-associated neurological conditions, such as Tourette’s and post-traumatic stress disorder. The FDA has designated CPP-115 orphan drug status in the U.S. for the treatment of infantile spasms. In Europe, for the treatment of West syndrome, it has been granted E.U. orphan medicinal product designation. In addition, the company is also developing a generic version of Sabril® (vigabatrin).

This prospectus offering is part of the company’s Shelf Registration Statement declared effective by the SEC on March 19, 2014. That enabled it to periodically sell its stock shares in the aggregate of $33,842,512, Catalyst Pharmaceuticals said in the new prospectus filing.

The company originally had 150 million shares of common stock and five million shares of preferred. Currently, it has 82,972,316 shares of common outstanding and no preferred shares outstanding.

The company expects to report to the FDA top line results in the second half of 2017 for its second phase 3 trial evaluating its candidate drug Firdapse® for the treatment of Lambert-Eaton Myasthenic Syndromes (LEMS). If the results are successful, the company expects to resubmit an NDA for Firdapse for the treatment of LEMS.

Further, if those test results are successful, the company expects to additionally provide evidence that Firdapse treats certain types of Congenital Myasthenic Syndromes (CMS) and request that CMS be included in its initial label.

Catalyst Pharmaceuticals, Inc., may also evaluate that drug for the treatment of myasthenia gravis and other rare neuromuscular diseases. No clinical programs for these indications have yet been developed, the company stated in the prospectus.

For CPP-115, the company intends to develop the drug for the treatment of epilepsy and Tourette’s syndrome. It would perform the required studies, subject to funding availability.

For more information, visit www.CatalystPharma.com

Annual Market Review Reveals OTC Markets Have Come of Age

February 21, 2017

After a century of service providing quotes on stocks and bonds to investors around the world, the OTC markets have come of age, and the recently published Annual Markets Review (http://dtn.fm/IW0iC) from OTC Markets Group, Inc. (OTCQX: OTCM) reveals that maturity. The company’s over-the-counter (OTC) platforms now host some 9,620 U.S. and global securities that generate an annual trading dollar volume of around $193 billion. Its OTCQX Best Market and OTCQB Venture Market provide price and liquidity information on some of the world’s best companies, and over 100 broker-dealers play an active part as market-makers. For companies, both big and small, being quoted on the OTC markets makes being public decidedly less painful.

The current tiered market structure makes it easier for companies to demonstrate their financial and corporate governance standards and to provide current information, avoiding the trading hurdles due to the opacity associated with the old pink sheets. The almost 10,000 securities included in the OTC Markets quotation system are organized into three markets, OTCQX, OTCQB, and Pink, to better inform investors.

The OTCQX Best Market is the premier quotation platform. To be quoted on the OTCQX market, a company must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws, and have a professional third-party sponsor introduction. Penny stocks, shell companies and companies in bankruptcy cannot qualify for OTCQX. The companies whose securities appear on the OTCQX are distinguished by the integrity of their operations and the diligence with which they convey their qualifications. The OTCQX Best Market, which welcomed some 50 new companies in 2016, offers transparent and efficient trading… without the cost and complexity of a U.S. exchange listing.

The OTCQB Venture Market is meant for early-stage and developing U.S. and international companies that are not yet able to qualify for OTCQX. To be eligible, a company must be current in its reporting and undergo an annual verification and management certification process. It must, also, meet a $0.01 bid test and may not be in bankruptcy. In 2016, 230 new companies joined the platform.

The Pink Open Market approximates most closely to the traditional pink sheets, although a particular market tier classification is not an indication of either the value of the security or an endorsement (or not) of the issuer. Market tiers are based only on the quality and timeliness of the information provided. OTCQB Venture Market and Pink Open Market quotes may be of securities for companies of high quality, as well as of those for speculative, distressed, or questionable companies.

Since May 16, 2013, the U.S. Securities and Exchange Commission (SEC) has considered the OTCQB and OTCQX marketplaces to be public marketplaces for purposes of establishing a public market price when registering securities for resale in equity line financings.

During 2016, the OTC Markets Group platforms passed some memorable milestones. Some 280 new companies made their debut on the OTCQX and OTCQB markets. In particular, the OTCQX shone under the spotlight: the OTCQX Best 50 companies (http://dtn.fm/0XznV) delivered an average total return of 130 percent compared to the S&P 500, which went up by 9.5 percent in 2016.

Twenty U.S. states now recognize the OTC markets for the purposes of their Blue Sky Manual Exemptions. Blue Sky laws are U.S. state securities laws designed to protect the public from securities fraud. The aim is to achieve Blue Sky recognition from all 50 states. In addition, seven share transfer agents participate in a new program that makes current verified information available to the public.

Client companies are voicing their approval of the measures to improve the OTC markets. As global information services giant Experian plc explained:

“…OTCQX offered a liquid trading platform for our ADRs, enabling US investors to invest directly in Experian stock via a US traded instrument, but it did not require us to list on a US exchange or register with the SEC. As a result, we continue to comply with the regulation and governance requirements of our primary London listing and are not subject to onerous duplicate regulation and governance requirements by virtue of our ADRs being traded in the US.”

It looks like the OTC Markets have definitely come of age by making being public much less painful.

For more information, please visit www.OTCMarkets.com

QualityStocks’ Tiered Rating Service Exposes Risk and Rewards Transparency

February 17, 2017

QualityStocks has rated more than 3,000 fully reporting OTC companies as an extension of its commitment to protect investors. Taking this commitment a step further, QualityStocks has also used the information gained from tracking hundreds of online newsletter firms to measure their legitimacy.

The OTC companies and research firms are rated based on their investor relations and transparency practices. QualityStocks has placed these companies into one of five tiers based on their compliance with market regulations, available information, transparency to shareholders, trust within the investor community, and the value of their product and/or services: QSP (QualityStocks Partner); QSV (QualityStocks Verified); QSL (QualityStocks Limited Information); QSN (QualityStocks No Information); and Caveat Emptor (Buyer Beware).

Trading OTC stocks poses a significant risk to any investor; those investors who are successfully managing an OTC portfolio know the importance of thorough due diligence. The QualityStocks rating service is a convenient and complementary tool designed to aid a trader’s individual research.

“Transparency is absolutely critical in this market. Our team has researched each company on our list to examine their fundamentals and apply an appropriate rating,” Michael McCarthy, Managing Director of QualityStocks, stated when originally announcing the service. “The result is a valuable tool that investors can use to quickly separate more trustworthy companies from more risky investments.”

To see the list of rated newsletter firms, visit: http://www.qualitystocks.net/ratings.php

To see the list of rated companies, visit: http://www.qualitystocks.net/companies.php

IntelliPharmaCeutics International, Inc. (NASDAQ: IPCI) Abuse Deterrent Technology featured at Healthcare Conference

The ‘2017 Disruptive Growth & Healthcare Conference’, which ran February 15-16 at the Convene at 730 Third Avenue Conference Center in midtown Manhattan, New York, featured some stellar participants, either as presenters or as sponsors. Along with over 60 other firms in a variety of fields related to biotech, IntelliPharmaCeutics International, Inc. (NASDAQ: IPCI) (TSX: I) was on the bill. The Toronto, Ontario-based company was scheduled to introduce its drug delivery technologies and exhibit its leading pipeline candidates.

The ‘2017 Disruptive Growth & Healthcare Conference’ hosted by RHK Capital, which formerly operated as Source Capital Group, was sponsored by leading investor relations and financial services firms, including NetworkNewsWire, a Platinum Sponsor.

With its drug delivery technologies built on the Hypermatrix™ platform, IPCI is targeting billion dollar markets. The company’s extended release (ER) (XR) formulations provide mechanisms to slowly dissolve and release constant amounts of a medication over time. Instead, of a patient having to take a pill three times a day, with the risk of losing count or forgetting, one daily dose will improve efficacy. Closer compliance with prescription rules results in better therapy.

ER formulations, widespread for leading indications, are expanding to new drugs. Medications that benefit from the IPCI technology include Oxycodone XR, Dexmethylphenidate ER, Venlafaxine ER, Desvenlafaxine ER, Levetiracetam ER, Lamotrigine ER and Pregabalin. Together, these pharmaceuticals present a market opportunity that exceeds $9 billion.

But a bigger prize is the market for abuse deterrent formulations (ADF), which attempt to fight prescription drug abuse by increasing the difficulty of inappropriate use of opioid medications. In the U.S., opioid abuse is on the rise. Data published by the American Society of Addiction Medicine reveals that in 2015 there were 21,101 deaths caused by opioid overdose. Opioids include licit substances such as codeine, fentanyl, hydrocodone and oxycodone, and illicit ones such as heroin and opium. This is a market estimated to be about $60 billion.

Apart from having its eye on these two lucrative opportunities, IPCI has a growing pipeline of new candidates that may lead to New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) filings. An NDA is filed when a sponsor believes there is enough evidence on a new drug’s safety and effectiveness to support FDA approval to bring it to market. An ANDA is required for generic drugs that are bioequivalent to a drug already being marketed.

IPCI has two novel NDA candidates, Rexista® and Regabatin XR™. Earlier this month, the company announced it had filed a New Drug Application (NDA) seeking authorization to market its Rexista™ abuse-deterrent oxycodone hydrochloride extended release tablets in the 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg strengths.

The FDA has determined that the company’s application is sufficiently complete to permit a substantive review, and has set a target action date under the Prescription Drug User Fee Act (PDUFA) of September 25, 2017. IPCI was able to demonstrate that Rexista™ is bioequivalent to OxyContin® (oxycodone hydrochloride extended release). With this upcoming milestone, IPCI will be setting another marker on its journey to success.

Founded in 1998 by the husband and wife team of Dr. Isa Odidi and Dr. Amina Odidi, IPCI has come a long way. The company now specializes in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals.

Based on this technology platform, Intellipharmaceutics has developed several drug delivery systems and a pipeline of products in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.

For more information, visit www.Intellipharmaceutics.com

The Diversification of Auxilio, Inc. (AUXO)

Auxilio, Inc. (NYST MKT: AUXO) is one of a select number of businesses headquartered in Mission Viejo, a mainly residential city in Orange County, California, and a closer look at this small yet booming business shows that it is unique not only for where its offices are based, but also for its value proposition.

Auxilio offers managed print services exclusively to the U.S. health care industry. A leader in this sector due to its innovative and customer-driven approach, Auxilio takes full responsibility for its health care clients’ on-site print environment through situation assessment, process analysis, strategy development and program implementation. The company also works closely with hospitals and hospital systems to deliver quality patient care and accomplishes this objective by providing a customized, scalable document solutions strategy that analyzes, remediates and manages document and print workflows from start to finish.

A vendor-independent company, Auxilio provides intelligent solutions, a risk-free program and guaranteed savings. It assumes all costs related to the print business environment by customizing, streamlining and seamlessly integrating its services at predictable fixed rates that are unmatched in the industry. As a result, its print management programs drive out costs, increase employee productivity and exceed patient care standards, and the hospitals and health systems that work with the company benefit from its streamlined and aligned processes and infrastructure.

For over 10 years, more than 200 of the leading hospitals and health systems in the U.S. have turned to Auxilio to resolve their broken document and digital workflow processes, and its document solutions have helped them reduce waste, safeguard protected health information (PHI) and improve operational efficiency while driving incredible cost savings. The company consistently delivers for its clients by leveraging its three core services lines: Managed Print Services, Document Consulting and iPLATFORM, an intelligent workflow automation suite.

According to the Orange County Business Journal’s 2016 Special Report (http://dtn.fm/C0x5k), from 2014 to 2016, Auxilio clocked more than 40% in growth, making it one of the fastest-growing public companies in the Orange County area. During this time, the company grew its existing business by continuously delivering excellent customer service, and it diversified into cyber security by acquiring two information technology security firms. The resulting demand for Auxilio’s cyber security services and rapid adoption of its Managed Print Services program by many large health care institutions contributed significantly to its recent swift growth.

For more information, visit www.AuxilioInc.com

New Age Beverages Corp. (NASDAQ: NBEV) Announces NASDAQ Capital Market Listing

February 16, 2017

Colorado-based New Age Beverages Corp. (NASDAQ: NBEV) has priced an underwritten public offering valued at approximately $15 million in gross proceeds and listing on the NASDAQ Capital Market, per a recent press release (http://dtn.fm/E8gLm). The corporation has also granted underwriters an additional opportunity to purchase 642,857 more shares of common stock. This 45-day option will enable them to purchase the extra shares to cover over-allotments. The total gross proceed amount is an estimate before underwriting discounts, commissions, and other offering expenses are deducted.

The company has already filed a registration statement with the Securities and Exchange Commission (SEC). Effective as of February 13, 2017, the filing relates to the securities now being offered. Acting as joint book-running managers are Aegis Capital Corp. and Maxim Group LLC. The recently issued offering will be made only by prospectus, a legal document that must be filed with the SEC, which is available by contacting New Age Beverages Corp. or by visiting the SEC website.

Founded in 2003, New Age Beverages Corp. markets several famous brands of beverages, such as XingTea®, Búcha® Live Kombucha, and Aspen Pure® Rocky Mountain Water. Marley Mellow Mood® Relaxation Drinks and Marley One Drop® Coffee are other products marketed by the company, following the signing of a management agreement in October 2016. The company is now competing in the health and functional beverage segment, a fast-growing area of the beverage market, and sells its brands in all 50 U.S. states. Its brands are also sold internationally, in over 10 countries, across all channels. Some have even gained notoriety. XingTea® recently beat over 250 competitors to earn the title of the ‘#1 Best Tasting Tea’ at the North American Tea Championship.

One of the largest independent distributors in the country, New Age Beverages Corp. reaches over 20,000 outlets from its distribution network in Colorado. It distributes over 60 different brands, representing over 600 SKUs of non-alcoholic and alcoholic beverages, snacks and specialty products. These include the all-natural, non-GMO Xing Energy drink. The employee-owned company recently merged with Marley Beverage Company, which was created in partnership with Bob Marley’s family and is a business that has become reputable in its own right. New Age Beverages Corp. is led by Chief Executive Officer Brent Willis. He has over 20 years of General Management, C-Level, and Board experience and has worked with the Coca-Cola Company (NYSE: KO), Kraft Heinz Company (NASDAQ: KHC), and other global leaders. The company has leveraged an organizational structure focused on testing product innovations, finding emerging products and segments early, and gaining credibility with national distributors.

New Age Beverages Corp. also distributes leading brands such as Nestea®, Nestle Nesquik®, Welch’s, and V8®, among a wide range of others. It understands the value of choosing healthy products. Focused on thinking big, changing the world, teamwork, and execution, the company delivers products that taste good and are affordable for retailers and consumers.

To find out more information, visit www.NewAgeBev.us

Singing Machine Company, Inc. (SMDM) Reports 9% Sales Growth for Nine Months, Debuts a Line for Kids

The Singing Machine Company, Inc. (OTCQX: SMDM) recorded revenue growth of 9% to $49.3 million for the nine months ended December 31, 2016, compared to $45.2 million for the comparable period in 2015 (http://dtn.fm/j9NfF). For the quarter ended December 31, 2016, sales dropped to $16.3 million compared to $20.7 million during the same period of the prior year. The company said that drop was due to the timing of shipments, which occurred earlier in 2016 than the prior year.

Singing Machine makes a line of karaoke products, offering the consumer access to some 1,300 songs. The music can either be downloaded or streamed. The Singing Machine home line is available in North America or internationally through mass merchant and online retailers. The company is also entering the toy business with Singing Machine Kids (http://dtn.fm/QyN7U), a range of 11 new products for children from preschool through elementary school. The line of sing-a-long products is being shown for the first time to buyers at the New York Toy Fair, February 18-21, 2017.

The company’s net income jumped 3.9% for the nine months ended December 31, 2016, to $2,685,561, up from $2,583,460 for the nine months ended December 31, 2015. For the three months ended December 31, 2016, sales dropped 21% to $16,319,804 compared to $20,667,069 for the comparable period the prior year. Similarly, net income dropped 35% to $1,312,158 for the three months ended December 31, 2016, from $2,006,913 during the same three-month period of the prior year.

Gary Atkinson, Singing Machine CEO, said, “This fiscal year we’ve grown net sales by 9% over last year and we’ve grown pre-tax net income by 33% to $4 million. On the product roadmap, we significantly expanded our distribution of our Digital Download Line of products and saw impressive growth in both downloading and streaming subscriptions.”

Bernardo Melo, VP of Sales, commented that ecommerce has grown to more than 18% of company sales. He said the company enjoyed an average 88% sell-thru across major retailers on both Black Friday and the Christmas season.

The company is unveiling its Singing Machine Kids line and will also, through its partnership with Stingray, offer a karaoke Sing-Along mobile app to be available in the fall. The app, available for both iOS and Android devices, will complement the Singing Machine Kids line.

The toy product line consists of 11 items, including:

  • Bluetooth Recording Studio, a portable studio with six sound effects loaded in advance.
  • Mic Guy Bluetooth Sing-Along, a battery operated system designed for the littlest singers.
  • Candy House Sing-Along, a joyful speaker system with a colored lit roof top.
  • Blackboard Calculator, designed to make math interactive and fun with the Wise Old Owl.

“We’re incredibly proud of our new kids line,” commented CEO Atkinson. “Not only have we designed a range of products that will enhance our mission of spreading joy through music, we have also created products that will help kids with a variety of early learning and developmental skills.”

For more information, visit www.SingingMachine.com

RegeneRX Biopharmaceuticals, Inc. (RGRX) Helping Patients with Multiple Sclerosis

February 6, 2017

Multiple Sclerosis, or MS, is a disease that damages the sheaths of nerve cells in the spinal cord and brain. This progressive disease causes symptoms such as severe fatigue, numbness, blurry vision, and impairment to muscular coordination and speech. According to statistics noted in Healthline (http://dtn.fm/uF91G), multiple sclerosis is now the most widespread disabling neurological condition in young adults around the world.

Furthermore, the Multiple Sclerosis Foundation now estimates that approximately 2.5 million people around the world have MS, with over 400,000 of these cases being in the U.S. Despite research being underway, the cause of MS is still not fully understood. In addition to the above, multiple sclerosis has been proven to be more prominent in women, with the ratio of women with MS to men with MS being about 2 to 1.

Currently, there is no cure for multiple sclerosis, but the treatments focus on speeding recovery from attacks, generally managing symptoms, and slowing the progression of the disease. Among the most commonly prescribed medications to treat MS are beta interferons, which are injected into a muscle or under the skin and reduce the severity and the frequency of relapses.

With this in mind, RegenRX Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical stage biopharmaceutical company focused on tissue protection, repair, and regeneration, has been developing RGN-352, an injectable Thymosin beta 4 formulation for the treatment of cardiac damage stemming from post-acute myocardial infarction (MI), chronic heart failure, and a variety of nervous system pathologies, including MS.

The drug successfully completed phase 1 clinical trials in 80 healthy subjects using an acute dose regimen. The preclinical studies showed Thymosin beta 4’s potent regenerative and protective effect on the central and peripheral nervous systems. RGN-352 increased the production of oligodendrocyte precursor cells by more than 200%.

In addition, the compound doubled the rate of oligodendrogenesis in the brain, reduced inflammatory infiltrates adjacent to brain vessels by 30%, and restored neurological function by 50%. Most recently, the company announced that it received a notice of acceptance for a patent from the Australian Patent Office for the use of Thymosin beta 4 for myelinate damaged neurons or axons.

For more information, visit www.RegeneRX.com

Marinus (NASDAQ: MRNS) Names Michael R. Dougherty to Board, Prepares to Initiate Phase 2 Studies of Ganaxolone

February 2, 2017

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), on February 1, 2017, named Michael R. Dougherty to its board. A biopharmaceutical company, Marinus is preparing to initiate phase 2 studies of ganaxolone, a drug which treats seizures and anxiety in patients suffering from epilepsy and neuropsychiatric disorders.

Dougherty has more than 30 years of experience in the biopharmaceutical industry. Most recently, he served as executive chairman of Celator Pharmaceuticals, Inc. Earlier, he served as CEO and a board member of Kalidex Pharmaceuticals, Inc. Dougherty also served in various capacities during his 10-year tenure with Adolor Corporation, including as president and CEO, a board member, COO, CFO and senior VP of commercial. Earlier still, he was at Genomics Collaborative, Inc., where he held the positions of president and COO. Dougherty is currently serving on the boards of Trevena, Inc.; Foundation Medicine, Inc.; Aviragen Therapeutics; and Cempra, Inc.

“This is an exciting time to join the Marinus board,” Dougherty stated in a news release. “Marinus is positioned to execute on several clinical studies with near-term milestones. I look forward to working with the Marinus board and management as we advance the development of the ganaxolone franchise.”

Ganaxolone is a drug candidate that acts on a well-characterized target in the brain and is known to have both anti-seizure and anti-anxiety effects. It is currently being evaluated in IV, capsule and liquid forms, and it’s designed for use in both hospital and home settings. Marinus is studying ganaxolone as a treatment option for both adult and pediatric patients.

Marinus is now preparing to begin a phase 2 clinical study of ganaxolone for the treatment of postpartum depression and status epilepticus (SE). A phase 2 clinical study of patients with SE will begin in 2017, the company said. Every dose regimen of ganaxolone IV to-date has been deemed generally safe and well-tolerated, reaching targeted dose levels in a short period of time. Any adverse events reported were mild and resolved without intervention, according to Marinus. Ganaxolone IV has been issued orphan drug designation from the U.S. FDA for the treatment of SE.

For more information, visit www.MarinusPharma.com

Monster Digital, Inc. (NASDAQ: MSDI) Tapping into Fast-Growing VR Market with High-Performance Cameras, Headsets

Until recently, virtual reality was typically the stuff of science fiction, a concept so innovative and unusual that it seemed highly unlikely to become reality anytime soon. For years, the concept remained almost exclusively tied to the futuristic images depicted by movies such as TRON or The Lawnmower Man. However, with rapid technological advancements in recent years, and due to the efforts of companies such as Facebook (NASDAQ: FB), with its Oculus VR, and Sony Corporation (NYSE: SNE), with its PlayStation VR, virtual reality has now become a part of our day-to-day lives, already having multiple applications in a number of industries, from health care to manufacturing, education, music, athletics and more.

Estimated to reach $126 billion by 2020, this fast developing market presents numerous growth opportunities for developers of VR products, apps and accessories. Simi Valley, CA-based Monster Digital, Inc. (NASDAQ: MSDI), a highly versatile designer and manufacturer of state-of-the-art consumer electronics and related products, has already seized the opportunity with its exclusive line of virtual reality products that includes high definition cameras and headsets, all designed and commercialized under its own brand.

Founded in 2010, Monster Digital is committed to manufacturing and delivering premium products and accessories for consumers and professionals who demand and expect to receive the very best. Its VR Product line includes the recently launched Monster Vision™ 360-degree VR camera, the Monster Vision™ VR camera set, two types of VR headsets (one of which has integrated headphones), and related accessories such as a waterproof VR camera case. The Monster Digital™ VR cameras allow users to record their adventures in a new way and to then share them with their friends and family or experience them from an entirely new perspective due to the 360-degree viewing capabilities.

In addition to VR products, the company also manufactures and commercializes a line of premium action sports cameras such as the high resolution Monster Digital™ Vision Plus 1080p+ camera and the more cost-competitive 720p action sports camera. Most of these models were on display at the Consumer Electronics Show in Las Vegas in early January.

Monster Digital also offers advanced data storage and memory products for use in mobile devices, cameras, tablets and more. The company’s data storage products are built to offer rapid transfer rates and high performance packed in a rugged, sturdy design. Available in multiple capacities, these memory products aim to help users achieve the best performance out of their devices. Additionally, Monster Digital designs the latest technology when it comes to solid state drives (SSD). The company’s SSDs offer peak performance and safe storage and are available both as external drives for desktop and laptop users, as well as internal upgrade kits for Apple (NASDAQ: AAPL) Macbook® and Intel (NASDAQ: INTC) Ultrabook® users.

For more information, visit www.MonsterDigital.com

Zogenix, Inc. (NASDAQ: ZGNX) Receives Patent for ZX008 in the Treatment of Dravet Syndrome

February 1, 2017

Zogenix, Inc. (NASDAQ: ZGNX) has been issued a patent by the U.S. Patent Office for its drug candidate ZX008. The award of this patent, according to the company, marks the first time a patent has been issued covering a fenfluramine treatment of Dravet Syndrome and the seizures associated with it (http://dtn.fm/v69uD). The patent is seen by the company as offering protection of associated claims through 2033.

“This represents the first issued patent covering the treatment of seizures associated with Dravet Syndrome using fenfluramine as an adjunctive therapy, and it is an important milestone for our ZX008 development program,” Stephen J. Farr, Ph.D., president and CEO of Zogenix, added in a news release.

The patent, titled ‘Method for the Treatment of Dravet Syndrome’, was announced by the company on January 30, 2017. Zogenix is currently in a phase 3 program with ZX008 and continues to enroll patients in the U.S. and globally. It has received fast track designation domestically for the treatment of Dravet syndrome, and ZX008 has been defined as an orphan drug in this indication in both the U.S. and Europe.

Zogenix, Inc., is a pharmaceutical company committed to producing commercially-viable central nervous system (CNS) therapies. The company is developing these products for individuals who require innovative treatments to help them with daily functioning.

Farr added that Zogenix is continuing to pursue additional patents related to ZX008 in order to provide additional protection for its lead candidate. The company is also performing more clinical and preclinical work as it seeks to target more intellectual property opportunities, he said.

Zogenix won worldwide patent rights and other intellectual property via its 2014 acquisition of Brabant Pharma Limited, pursuant to a purchase and sales agreement executed with Brabant, the company said.

In its SEC filing of November 8, 2016, Zogenix reported that, in October 2016, it extended through April 2017 its manufacturing services agreement with Pantheon UK Limited. It can be extended again, the company reported. Future purchase minimum obligations totaled $4.6 million at September 30, 2016, through the extension date.

Also on October 2016, Zogenix entered into an asset purchase agreement for $1.5 million to buy the global rights to a preclinical development program for orphan CNS disorders. The company is bound to make future milestone payments over several years, but in the SEC filing Zogenix termed those payments ‘inherently uncertain’ due to the preclinical stage of development.

For more information, visit www.Zogenix.com

Palatin Technologies, Inc. (PTN) Takes Bremelanotide to Phase 3 Clinical Trials for Hypoactive Sexual Desire Disorder (HSDD)

January 31, 2017

Hypoactive Sexual Desire Disorder, or HSDD, is a common female sexual dysfunction where the woman feels a decrease in sexual desire and an increase in personal distress from this lack of desire. It’s a disorder affecting approximately one in 10 women, and it often leads to relationship issues. According to ‘Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment’ (http://dtn.fm/H565a), HSDD is present in just under 9% of women aged 18 to 44, over 12% of women aged 45 to 64, and over 7% of women aged over 65.

The report continues to explain that more than half of women suffering from HSDD do not seek help from their doctors or physicians. This has been largely attributed to fear and embarrassment. Despite there being a tool called ‘The Decreased Sexual Desire Screener’, available in general practices, HSDD still remains underdetected and undertreated. However, there are also new drugs being developed for the treatment of HSDD.

In 2015, a drug called Addyi (flibanserin) was approved by the Federal Drug Administration (FDA) as the first centrally acting daily medication for HSDD. Recently, Palatin Technologies, Inc. (NYSE MKT: PTN) announced Phase 3 development of Bremelanotide. Based on the biopharmaceutical company’s findings, Bremelanotide is thought to have several distinct advantages over Addyi.

Bremelanotide has a different form of administration than Addyi. Bremelanotide can be taken as needed with an onset of efficacy in approximately 30 minutes, effective for a period of eight to 10 hours. In addition to this, the drug is not expected to have a boxed warning, unlike Addyi, which has the potential of causing hypertension and syncope in certain settings.

Bremelanotide is also not believed to interact with alcohol, or have any contraindications. On the other hand, patients taking Addyi are advised to abstain from alcohol and the drug is not to be used with strong CYP3A4 or in patients with hepatic impairments, as this could increase the risk of hypertension and syncope.

The Phase 2B clinical trials involved 327 female patients, some taking Bremelanotide and others a placebo, at home, for a 20-week period. All patients suffered from some form of female sexual dysfunction. The results showed a 50% increase in Satisfying Sexual Events (SSEs) with Bremelanotide, compared to a 12% increase with placebo. Other factors that improved included an improvement in overall sexual function and a decrease in personal distress from the sexual dysfunction.

Currently, PTN’s Bremelanotide is in Phase 3 development as a treatment for hypoactive sexual desire disorder in premenopausal women. The pivotal Phase 3 clinical trials were initiated in December 2014 and January 2015, respectively, with the efficacy portion completed back in August 2016. The topline data for the drug is expected to be available in the fourth quarter of 2016. If the data is positive, the data will support an NDA filing in 2H2017 and potential NDA approval in 2H2018.

For more information, visit www.Palatin.com

Singlepoint, Inc. (SING) CEO Discusses Cannabis Industry Game Plan in Interview with CFN Media Group

January 30, 2017

Before the opening bell, CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announced the release of an exclusive interview with Singlepoint, Inc. (OTC: SING) CEO Greg Lambrecht. In the interview, Lambrecht takes a look at the current state of the legal cannabis industry, particularly as it relates to banking, which is an area that Singlepoint is currently targeting through its SingleSeed subsidiary. In addition to providing some insight into the company’s early-mover advantage in the burgeoning market, Lambrecht used the interview to offer prospective investors some additional insight into Singlepoint’s strategy to capitalize on proposed reform to the regulations that are currently impeding the use of banking services for the legal cannabis industry.

To view the full interview, visit http://dtn.fm/Rzx9S

The legal cannabis industry is expected to record tremendous growth in the coming months, driven primarily by California and the three other states that voted to legalize the substance for recreational purposes last November. According to Cowen & Co., the industry could record revenues in excess of $50 billion by 2026, creating a lucrative opportunity for companies operating in the space.

Despite the fact that well over half of all states have now legalized marijuana in some form, the drug remains illegal at the federal level. This inconsistency has caused most commercial banks around the country to keep their distance. Since the last guidelines from the Financial Crimes Enforcement Network (FinCEN) were released in 2014, less than three percent of the nearly 12,000 federally regulated banks and credit unions have made the decision to serve the cannabis industry.

In recent weeks, lawmakers have initiated a movement to correct this oversight. Massachusetts Senator Elizabeth Warren, in concert with nine other U.S. senators, recently penned a letter to FinCEN calling for improved guidelines that could help correct the ‘cash-only’ modus operandi that’s currently in play for the vast majority of legal cannabis businesses. Warren noted a variety of potential benefits that could stem from this reform, including more reliable tax records and improved all-around safety for dispensaries and similar operations.

Singlepoint, through its SingleSeed subsidiary, is primed to capitalize on this proposed reform. The company initially recognized the enormous potential for cannabis credit card processing years ago, when it placed cashless ATMs at roughly 200 medical and recreational dispensaries in Colorado and Washington. Unfortunately, regulatory red tape forced Singlepoint to temporarily suspend those operations, but the company’s growing list of interested clients in the space could create a tremendous opportunity if and when lawmakers address the cannabis banking problem.

In preparation for anticipated reform, Singlepoint has already launched SingleSeed.com in an effort to expand its existing customer base in the cannabis industry. The company recently launched a connect-by-text marketing platform for cannabis businesses that allows them to seamlessly communicate with customers in a way that doesn’t run afoul of strict cannabis marketing regulations. These efforts, when combined with Singlepoint’s aggressive acquisition strategy, played a key role in CFN Media Group’s classification of the company as a “compelling opportunity within the cannabis payments space.”

For more information, visit the company’s website at www.Singlepoint.com

Let us hear your thoughts: Singlepoint, Inc. Message Board

VPR Brands, LP (VPRB) Showcasing New Vaping Solutions for Fast-Growing Cannabis Market

January 26, 2017

VPR Brands, LP (OTC: VPRB), a manufacturer and provider of electronic cigarette and vaping solutions based on both U.S. and Chinese patents, has big plans for the year on the heels of the recent legalization of medical and recreational use of marijuana in several states. Most of the company’s vaping products can be easily used by the legal marijuana industry, presenting VPR Brands with an impressive opportunity for rapid growth. In addition, the company also has plans to further expand its product offerings to include specific cannabis vaping products such as the STINGER vaping stick and an entirely new brand destined to all cannabis packaging, SAFRx.

Founded in 2004, the Miami, Florida-based VPR Brands owns patents for various atomization products and other types or vaping technology, from electronic cigarettes and accessories to medical marijuana vaporizers and more. The company also develops private label manufacturing programs, most notably for e-liquid, with a capacity of more than one million bottles per month. VPR Brands’ private label e-liquid manufacturing program is available for both manufacturers who simply want to tweak their own formulas and those who want to expand their lines. The company constantly expands its flavor line and also offers reverse flavor engineering services. The e-liquid is manufactured in a state-of-the-art facility and undergoes rigorous quality control testing before being delivered to the end customer.

In addition to its private label services, VPR Brands offers vaping technology ranging from vaporizers to electronic cigarettes and related accessories under various established brand names, such as Helium, a line of e-liquids and chillers; HoneyStick™, the first ceramic sub-Ohm oil device available in three different sizes; Krave®, a line of electronic cigarettes with related kits and accessories; Vaporin™, a premium line of e-liquids, vaporizers and electronic cigarettes; and VaporX®, a line of sophisticated, high-quality vaporizers, premium e-liquids, e-cigs, cartridges and accessories.

As part of the HoneyStick™ brand, the company recently relaunched its flagship product, the STINGER vaporizer for cannabis concentrates. The fully ceramic unit, with its sleek and elegant design, was showcased as one of the best performing and versatile ceramic vaping pens at the 2017 BIG Industry Show in Los Angeles last week. Present at the show, VPR Brands CEO Kevin Frija and COO Dan Hoff said they expect California to become an even larger market for cannabis-related products this year, following the state’s vote to legalize recreational adult use alongside medicinal use of the substance. Industry analysts expect annual sales of marijuana in California to reach a total of $7.6 billion by 2020.

VPR Brands is also attending the TPE Tobacco Plus Expo in Las Vegas on January 25-26 to showcase its newest product portfolio for 2017. Most of these new products have not yet been released to the public, but initial response has been very encouraging, Frija said, adding that the new portfolio will become available via retail as of the second and third quarters of the year. The company’s management expects a high turnout from the cannabis sector at the show – the first major industry expo to take place in Nevada since the state voted to legalize recreational marijuana use. The legal marijuana market in the state is expected to grow from $121.6 million last year to about $630 million by the year 2020.

For more information, visit www.VPRBrands.com

First Bitcoin Capital Corp. (BITCF) Signs Distributorship for ATMs Targeting Cannabis Dispensaries

January 25, 2017

First Bitcoin Capital Corp. (OTC: BITCF) has signed a master distributorship for a new type of check-cashing ATM designed for use in medical cannabis dispensaries in California. The Vancouver, B.C.-based company offers a full line of financial services for the medical marijuana industry. The specially-designed ATMs offer check cashing services and are designed specifically for use in medical marijuana dispensaries. The company said it expects these ATMs will increase the customer base in these locations by 18%.

First Bitcoin Capital Corp. is a developer of services related to bitcoin and cryptocurrency. It offers financial solutions for high-risk merchants, including medical marijuana dispensaries. Its financial services are needed to make it easy for clientele to cash checks. The new ATMs are specially designed to serve large and established medical marijuana dispensaries, and they have sophisticated risk analysis algorithms and underwriting procedures.

The Federal Deposit Insurance Corporation (FDIC) believes that approximately 7% of U.S. households are unbanked, referring to a 2015 National Survey of Unbanked and Underbanked Households (http://dtn.fm/ve6Nm). That survey indicated that about nine million households in the U.S. were unbanked. Another 19.9% of households, or 24.5 million, the study showed, were underbanked. This is defined as a household having a checking or savings account, but using financial services outside of the conventional banking system. Members of this group used payday, pawn shop, or auto title loans. Almost 70% said they used ATMs/kiosks to access their bank accounts.

The ATM machines to be distributed by First Bitcoin Capital Corp. will enable consumers to cash payroll, government, and personal checks, as well as money orders. The fully-automated ATMs will process the needs of unbanked customers who may need to cash checks before purchasing. This is seen by the company as an attractive feature for dispensaries, making check cashing convenient for its clientele.

First Bitcoin said it is also developing a system that would allow dispensaries to accept Bitcoin and other cryptocurrencies as legal payment. First Bitcoin is tailoring its financial services to the unique needs of the medical cannabis industry.

For more information, visit www.BitcoinCapitalCorp.com

ITUS Corporation (NASDAQ: ITUS) is “One to Watch”

It is no secret that cancer remains a global epidemic. According to The National Cancer Institute (http://dtn.fm/RK8lF), cancer is still one of the leading causes of death in the world, with more than 8.2 million cancer-related deaths back in 2012. The American Cancer Society (http://dtn.fm/RK8lF) estimates that in 2017, just in the U.S., there will be over 1.6 million new cancer cases, with more than 600,000 cancer-related deaths, and the number of new cancer cases is expected to rise to 22 million within the next 20 years.

Some of the most common types of cancer expected in 2017 include breast cancer, lung and bronchus cancer, prostate cancer, colorectal cancer, melanoma of the skin, and urinary bladder cancer, with lung and bronchus cancer expected to be the biggest killers. Each of the types of cancer listed above needs to be detected early in order for patients to have the best survival rates, something made possible only with effective cancer screening tests.

ITUS Corporation (NASDAQ: ITUS), a company in the business of developing a series of non-invasive, inexpensive blood tests in order to detect cancer early on, has come up with Cchek™, a new form of cancer screening test that has proven to be more accurate, reliable, easy, and affordable than current screening tests. Cchek™ is a diagnostic platform that focuses on a subset of cells that are said to appear at the beginning of the formation of a tumor. By using proprietary protocols and fluorescently labeled antibodies, Cchek™ counts and sorts the specific and rare cells.

Currently, Cchek™ has been validated with 14 cancer types and has tested 315 patients, with 225 testing positive for cancer and 87 testing negative. In the preliminary results, the company achieved sensitivity and specificity of 92% accordingly for 88 patient samples, including 54 samples from patients with a variety of types of cancer, and 34 healthy patients. Sensitivity and specificity are two scientific measurements that are used to establish the efficacy of a diagnostic test.

ITUS Corporation is in the process of submitting its data at scientific meetings and plans to publish its data shortly. The company is continuing to process new patient samples with the aim of testing new cancer types while evaluating benign conditions. Currently, ITUS is still undertaking double-blinded testing in order to take Cchek™ to the U.S. Food and Drug Administration (FDA) for future approval.

For more information, visit www.ITUSCorp.com

Westell Technologies, Inc. (NASDAQ: WSTL) Advancing Network Performance with Innovative Solutions

January 23, 2017

Since its inception back in 1980, Aurora, Illinois-based Westell Technologies, Inc. (NASDAQ: WSTL) has had one primary goal: that of ensuring top-quality communications to its customers. Almost four decades ago, this meant offering highly efficient transmission equipment and telephone signaling, but since then the company has expanded significantly and adapted to now offer some of the most technologically advanced, high-performance wireless infrastructure solutions in the telecom industry. Westell Technologies offers a comprehensive set of innovative products and service geared toward advancing network performance and helping network operators and service providers lower operating expenses. Serving primarily the U.S. market, Westell has expanded to also offer its products and services to Canada, South America, Africa, and Australia.

Westell’s innovative product solutions include Intelligent Site Management (ISM), Communication Network Solutions (CNS) and In-Building Wireless (IBW) via proprietary Clearlink® technology. The ISM solution helps users gain a competitive advantage when it comes to control and operation of their networks through remote visibility, a unitary control platform, lower operating costs, flexibility, adaptability, quality and maximum efficiency. Given the rapid expansion of wireless networks and the growing challenges this poses, the focus is now more on remote site management so as to lower maintenance costs and minimize troubleshooting. Westell provides comprehensive site management focused on communications management, power and security management and environmental management.

The company’s CNS include state-of-the-art network interfaces, power distribution systems, cabinets and enclosures, cell site optimization, system integration and also copper fiber management. The main goal of the company’s CNS is to help build reliable communications networks that can sustain harsh environmental conditions and still be able to connect any outdoor facility or building effectively, safely and efficiently.

Westell’s IBW segment is based on the company’s proprietary Clearlink® technology and includes various comprehensive solutions designed to ensure wireless coverage and capacity. IBW solutions include small cell deployments and distributed antenna systems, which are becoming increasingly common due to a significant spike in the use of mobile devices and data-intensive mobile services in office buildings, universities, airports and other public venues. The company’s Clearlink® IBW solution includes antennas, distributed antenna system radiofrequency conditioners, bi-directional amplifiers, digital repeaters and other types of system components aimed at improving overall network performance while lowering capital and operating costs.

In addition to its three main product groups, Westell also offers a comprehensive range of support and services to its customers so as to put together customized, complete solutions that best meet their business needs. Leveraging its 35+ years of experience in providing quality, innovative service to the industry, Westell makes available important technical knowledge and integration services, as well as training classes and general support designed to help all of its customers, from service providers to tower operators and other network operators.

For more information, visit www.Westell.com

Function(x) Inc. (NASDAQ: FNCX) Stole a March on the Women’s March with Wetpaint for Millennial Women

The hundreds of thousands of women who attended the Women’s March on Washington and its ‘sister’ marches across the nation and around the world attest to the magnitude of ‘girl power’. The status of women has certainly changed from what it was in the 15th century, when the English clergyman, John Mirk, wrote in a homily that survives, slightly altered, to this day: a maid should be seen, but not heard.

The multitude of maids that paraded across Independence Avenue and at other locations was certainly seen and definitely heard. The modern woman takes an active role in public affairs, but she also indulges her fancy for lighter fare by visiting the Function(x) Inc. (NASDAQ: FNCX) website Wetpaint, which, for over six years now, has been serving millennial women with the latest entertainment scoops, including television, music, and pop culture news.

Millennials, or those born between 1982 and 2000, make up about one-quarter of the U.S. population. At 83.1 million, they now outnumber the 75.4 million Baby Boomers, according to recent Census Bureau (http://dtn.fm/BlAo7) data. Their numbers mean they cannot be ignored.

A feature on NewsCred Insights (http://dtn.fm/pNS12) stressed the need for those who market to Millennials to have relevant content. It also pointed out that you can ‘catch Millennials where they live: on social media’. Millennial women, it seems, make up the majority of users on social media platforms such as Facebook, Pinterest and Instagram. Men prefer online discussion forums like the once profanity-laced Reddit. Gender differences on Twitter, Tumblr and LinkedIn are not, according to the Pew Research Center (http://dtn.fm/yX1BZ), significant. Most fascinating of all was the discovery that 70 percent of millennial women consider shopping to be entertainment. Who would have guessed?

That’s why, in 2010, Function(x) launched the Wetpaint Entertainment platform designed to offer the 18–34 year old female demographic information, entertainment and information on entertainment. On Wetpaint, Generation Y females can get the latest updates and breaking news on TV shows, celebrities, reality gossip, music, and fashion. The site, which depends on an advertising-based revenue model, publishes more than 55 new articles, videos and galleries each day.

To enhance its digital publishing business, Function(x) recently acquired the assets of Rant Inc., a leading digital publisher of original content across 13 different verticals, most notably in sports, entertainment, pets, cars, and food. The combined Wetpaint and Rant properties currently have approximately 13.5 million fans on their Facebook pages and generate an average of 14.4 million visits per month.

Another Function(x) property is Choose Digital, a white-label digital marketplace featuring a wide up-to-date range of digital content, including music, movies, TV shows, e-Books and audio books. The site offers an aggregation of movie and TV content plus content sourced from the world’s leading record companies and book publishers.

Function(x) also offers a daily fantasy sports experience both directly to consumers and to businesses desiring turnkey solutions through its majority ownership of DraftDay Gaming Group, which is well-positioned to become a significant player in the explosive fantasy sports market.

For more information, visit www.FunctionxInc.com

Archives

Select A Month
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Search

    Categories

    Select A Category
  • 21st Century Holding Company TCHC (1)
  • 5BARz International Inc. BARZ (12)
  • 5G Wireless Communications Inc. FGWC (8)
  • A.P. Pharma Inc. APPA (3)
  • Abazias Inc. ABZA (2)
  • ABV Gold ABVG (11)
  • ACME Sports & Entertainment Inc. ASEN (2)
  • Adaptive Medias Inc. ADTM (6)
  • Advanced ID Corp. AIDO (5)
  • Advanced Medical Isotope Corp. ADMD (10)
  • Advanced Resources Group Ltd. AVRG (3)
  • Advanced Viral Research Corp. ADVR (9)
  • Advanced Visual Systems Inc. AVSC (10)
  • Advanced Voice Recognition Systems Inc. AVOI (11)
  • Advanced Wound Technologies Inc. AWTM (4)
  • Advaxis Inc. ADXS (2)
  • Agora Holdings Inc. AGHI (33)
  • Ahead of the Bulls (1)
  • AISystems, Inc. ASYI (11)
  • Aladdin Trading & Company ADTD (29)
  • All American Gold Corp AAGC (13)
  • All Asia Licensing Inc. AASI (1)
  • ALL Fuels & Energy Company AFSE (49)
  • All Grade Mining Inc. HYII (3)
  • All Penny Stocks (3)
  • Allarae Healthcare Inc. ALHI (5)
  • Alliance Creative Group ACGX) (15)
  • Alliance Recovery Corp. ARVY (34)
  • AlphaTrade.com APTD (2)
  • Alpine TLI Group Inc. APGR (7)
  • ALR Technologies Inc. ALRT (9)
  • Alternative Construction Technologies Inc. ACCY (10)
  • Alternative Energy Development Corp. ADEC (1)
  • Alternative Fuel Technology Inc. AFTC (1)
  • Alternet Systems Inc. ALYI (47)
  • AM Oil Resources & Technology Inc. AMOR (8)
  • Amarin Corp. AMRN (2)
  • Amaru Inc. AMRU (2)
  • Amerex Group, Inc AEXG (16)
  • American Capital Partners Inc. APRJ (1)
  • American Fiber Green Products Inc. AFBG (1)
  • American Oriental Bioengineering Inc. AOB (3)
  • American Racing Capital Inc. AMRA (2)
  • American Software (2)
  • Amgen Inc. AMGN (2)
  • AmMex Gold Mining Corp. AMXG (2)
  • Ampex Corp AMPX (1)
  • Andover Medical Inc. ADOV (2)
  • Angstrom Microsystems Inc. AGMS (46)
  • Apolo Gold and Energy Inc. APLL (1)
  • Apple Inc. AAPL (13)
  • Aquasil International Inc. AQUS (3)
  • Armco Metals Holdings Inc. AMCO (36)
  • AspenBio Pharma APPY (1)
  • Assured Pharmacy Inc. APHY (1)
  • Asta Funding Inc. ASFI (2)
  • Atlantic Energy Solutions Inc. AESO (1)
  • ATSI Communications Inc. ATSX (1)
  • Augme Technologies Inc. AUGT (70)
  • Auric Mining Corp. AUMY (3)
  • Automated Vending Technologies Inc. AVTC (3)
  • Automotive Company GNAU (11)
  • Avalon Oil and Gas Inc. AOGN (16)
  • Avant Diagnostics Inc. AVDX (29)
  • Avatar Systems Inc. AVSY (3)
  • Axiom Management Inc. AXMA (3)
  • Axis Technologies Inc. AXTG (2)
  • B2Digital Inc. BTOD (18)
  • Balatia Airlines BLTA (2)
  • Bald Eagle Energy Inc. BEEI (18)
  • Banjo & Matilda Inc. BANJ (8)
  • Barchart.com (4)
  • Beacon Enterprise Solutions Group BEAC (47)
  • Beacon Equity Research (552)
  • Beijing Med-Pharm Corp. BGJP (2)
  • Bergamo Acquisition Corp. BGMO (15)
  • Big Tree Group Inc. BIGG (36)
  • Bio-Clean International Inc. BCLE (1)
  • Bio-Matrix Scientific Group Inc. BMSN (1)
  • BioCentric Energy Holdings Inc. BEHL (1)
  • Biomagnetics Diagnostics Corp. BMGP (3)
  • bioMETRX Inc. BMRX (1)
  • Bionic Products Corp. BNPD (4)
  • Biophan Technologies Inc. BIPH (1)
  • BioSolar Inc. BSRC (22)
  • Biotech Holdings Ltd. BIOHF (3)
  • BizRocket.com Inc. BZRT (9)
  • Black Diamond Brands Corp. BDMHF (1)
  • Blue Diamond Ventures Inc. BLDV (1)
  • Blue Water Global Group Inc. BLUU (7)
  • Blugrass Energy Inc. BLUG (4)
  • BoonMarket.com (1)
  • Boreal Water Collection Inc. BRWC (23)
  • Boston Therapeutics Inc. BTHE (20)
  • Bridgetech Holdings International Inc. BGTH (1)
  • Brighton Oil & Gas Inc. BROG (8)
  • Britannia Mining Inc. BMIN (14)
  • Brite Strike Tactical Illumination Products, Inc. BSTI (41)
  • Brookside Technology Holdings Corp BKSD (2)
  • Bullzi Security Inc. BLLZ (3)
  • BWI Holdings Inc. BWIH (165)
  • Cal-Bay International Inc. CBYI (6)
  • Callisto Pharmaceuticals, Inc. (1)
  • Calpian Inc. CLPI (27)
  • CAMAC Energy Inc. CAK (2)
  • Canam Energy Inc. CNGJ (10)
  • CanAm Uranium Corp. CAUI (58)
  • Cannabics Pharmaceuticals Inc. CNBX (14)
  • Capital City Energy Group Inc. CETG (18)
  • Car Monkeys Group CKMY (15)
  • Carbon Sciences Inc. CABN (21)
  • CardioVascular BioTherapeutics Inc. CVBT (5)
  • Cardium Therapeutics Inc. CXM (44)
  • Cascade Technologies Inc. CSDT (2)
  • Cascadia Investment Inc. CDIN (4)
  • Casey Corp. CCPR (1)
  • Cashcow Magazine (4)
  • Cavico Corp. CVIC (3)
  • CD International Enterprises Inc. CDII (23)
  • CDC Corp. CHINA (4)
  • CelebDirect Inc. CELI (3)
  • Cellceutix Corp. CTIX (18)
  • CellCyte Genetics Corp. CCYG (3)
  • Century Group, Inc. CEYG (1)
  • CEOcast (184)
  • CepTor Corp. CEPO (1)
  • Cereplast Inc. CERP (9)
  • Chancery Resources Inc. CCRY (3)
  • Changing Times Vitamins Inc. SGTB (12)
  • CHDT Corp. CHDO (5)
  • Cherubim Interests Inc. CHIT (36)
  • China 3C Group CHCG (13)
  • China America Holdings Inc. CAAH (8)
  • China Direct Inc. CDS (4)
  • China Education Alliance Inc. CEUA (4)
  • China Energy Recovery Inc. CGYV (12)
  • China Growth Development Inc. CGDI (2)
  • China Health Management Corp CNHC (7)
  • China Health Resource Inc. CHRI (14)
  • China INSOnline Corp. CHIO (1)
  • China Jiangsu Golden Horse Steel Ball Inc. CJGH (3)
  • China Logistics Group Inc. CHLO (11)
  • China Media Group Corp. CHMD (2)
  • China Medicine Corporation CHME (5)
  • China Nuvo Solar Energy Inc. CNUV (3)
  • China Organic Agriculture Inc. CNOA (11)
  • China Petroleum and Chemical Corp. SNP (2)
  • China Voice Holding Corp. CHVC (47)
  • China Wind Systems Inc. CWSI (6)
  • China Wireless Communications Inc. CWLC (4)
  • China Yongxin Pharmaceuticals Inc. CYXN (5)
  • China YouTV Corp. CYTV (1)
  • ChinaTel Group Inc. CHTL (1)
  • Chineseinvestors.com, Inc. CIIX (9)
  • ChromaDex Corp. CDXC (3)
  • City Capital Corp. CTCC (2)
  • Cityside Tickets CIST (21)
  • CleanTech BioFuels Inc. CLTH (10)
  • Cleantech Transit Inc. CLNO (3)
  • Clearly Canadian Beverage Corp. CCBEF (13)
  • Cleartronic Inc. CLRI (52)
  • Clenergen Corp. CRGE (37)
  • CMG Holdings Inc. CMGO (2)
  • Coastal Integrated Services Inc. COLV (13)
  • Coil Tubing Technology Inc. CTBG (1)
  • Colorado Goldfields Inc. CGFI (5)
  • Colt Resources Inc. COLTF (13)
  • Columbia River Resources Inc. CRVR (1)
  • CoMedia Corp. CMTN (1)
  • CommercePlanet Inc. CPNE (4)
  • Compress Technologies Inc. CTLG (17)
  • Conforce International Inc. CFRI (2)
  • Connect-A-Jet.com CAJT (9)
  • Cono Italiano Inc. CNOZ (12)
  • Consorteum Holdings, Inc. CSRH (160)
  • ContentChecked Holdings Inc. CNCK (60)
  • Continental Fuels Inc. CFUL (2)
  • Convergence Technology Group Inc. CNVC (7)
  • Copper King Mining Corp. CPRK (2)
  • Cord Blood America Inc. CBAI (102)
  • Crdentia Corp CRDT (12)
  • Creative Vistas Inc. CVAS (2)
  • Crystal International Travel Group Inc. CINT (4)
  • Cubic Energy Inc. QBC (2)
  • Cybermesh International Corp. CYTL (1)
  • Cyclone Power Technologies Inc. CYPW (9)
  • CYIOS Corp. CYIO (1)
  • Daily Views (13)
  • Dakshidin Corp. DKSC (5)
  • Data Call Technologies Inc. DCLT (25)
  • Daulton Capital Corp. DUCP (26)
  • Davi Skin Inc. DAVN (1)
  • Debt Resolve Inc. DRV (2)
  • Debut Broadcasting Corporation Inc. DBTB (1)
  • Deep Blue Marine Inc. DPBM (6)
  • Deep Down Inc. DPDW (15)
  • Deer Valley Corp. DVLY (2)
  • Defense Solutions Inc. DFSH (3)
  • Delta Mining and Exploration Corp. DMXC (1)
  • Dermisonics Inc. DMSI (1)
  • Destination Television Inc. DSTV (17)
  • Dhanoa Minerals Ltd. DHNA (4)
  • DigitalPost Interactive Inc. DGLP (8)
  • Document Capture Technologies Inc. DCMT (3)
  • DoMark International Inc. DOMK (29)
  • Dominovas Energy Corp. DNRG (72)
  • Dragon Capital Group Corp. DRGV (11)
  • Dragon International Group Corp. DRGG (2)
  • Duma Energy Corp. DUMA (20)
  • Duska Therapeutics Inc. DSKA (1)
  • Dutton Associates (88)
  • DXP Enterprises Inc. DXPE (4)
  • Dynamic Media Holdings Inc. DYMH (6)
  • Dynamic Response Group Inc. DRGP (6)
  • Dynasty Limousine Inc. DNYS (19)
  • Earth Dragon Resources Inc. EARH (10)
  • Eastbridge Investment Group Corp. EBIG (1)
  • Ebenefits Direct, Inc. EBFD (21)
  • eCareer Holdings Inc. ECHI (9)
  • Echo Therapeutics Inc. ECTE (5)
  • EcoloCap Solutions Inc. ECOS (2)
  • Ecologic Transportation Inc. EGCT (11)
  • Ecosciences Inc. ECEZ (1)
  • Ecotality, Inc. ECTY (67)
  • eCrypt Technologies Inc. ECRY (79)
  • EdgeTech International Inc. EGIL (6)
  • eDoorways Corp. EDWY (183)
  • EFoodSafety.com Inc. EFSF (4)
  • EFuel EFN Corp. EFUL (1)
  • EGPI Firecreek Inc. EFIR (1)
  • Elephant Talk Communications Corp. ETAK (8)
  • Elephant Talk Communications Inc. ETAK (2)
  • Elleipsis Global Travel Solutions Inc. EGTS (3)
  • Elray Resources Inc. ELRA (11)
  • Elron Electronic Industries Ltd. ELRN (1)
  • Emerging Media Holdings Inc. EMDH (22)
  • Empire Energy Corporation International EEGC (3)
  • Endeavor Explorations Inc. EAVR (7)
  • Endeavour Silver Corp. EXK (3)
  • Endevco Inc. EDVC (2)
  • Energtek Inc. EGTK (61)
  • Enherent Corp. ENHT (2)
  • EnterConnect Inc. ECNI (5)
  • Enterprise Oilfield Group Inc. E.TO (13)
  • EnXnet Inc. EXNT (1)
  • Epazz Inc. EPAZ (22)
  • Equity Stock Analysis (1)
  • ER Urgent Care Holdings Inc. ERUC (6)
  • ERF Wireless Inc. ERFB (15)
  • Essential Innovations Technology Corp. ESIV (2)
  • Etelcharge.com Inc. ETLC (3)
  • Euoko Group Inc. EUOK (2)
  • EV Innovations Inc. EVII (189)
  • EV Transportation Inc. EVTP (7)
  • Exchange Media Corp. EXMD (9)
  • Exeter Resource Corp. XRA (2)
  • eXp World Holdings, Inc. EXPI (73)
  • Expert Group Inc. EXPT (5)
  • ExpressIR Inc. (1)
  • Extreme Motorsports of California, Inc. EMOC (26)
  • ezBanc-A Stocklender's Journal (6)
  • Falcon Crest Energy FCEN (75)
  • Falcon Ridge Development Inc. FCNR (2)
  • Famous Uncle Als Hot Dogs & Grille Inc FDOG (10)
  • Fastfunds Financial Corp. FFFC (17)
  • Financial Media Group, Inc. FNGP (26)
  • Financial Services Exchange FSE (1)
  • First Titan Corp. FTTN (45)
  • FlexWeek Inc. FXWK (11)
  • FluoroPharma Medical Inc. FPMI (46)
  • Foldera, Inc. FDRA (11)
  • Force Energy Corp. FORC (5)
  • FormCap Corp. FRMC (29)
  • Fortune Market Media Inc. FTMM (5)
  • Franklin Mining Inc. FMNJ (1)
  • Freedom Leaf Inc. FRLF (12)
  • Fresh Harvest Products Inc. FRHV (7)
  • Fresh Promise Foods Inc. FPFI (12)
  • Freshstart Properties Inc. FSPP (1)
  • FrogAds Inc. FROG (6)
  • Frozen Food Gift Group Inc. FROZ (5)
  • Fund.com, Inc. FNDM (56)
  • Fushi Copperweld Inc. FSIN (2)
  • GainClients Inc. GCLT (9)
  • Galenfeha Inc. GLFH (28)
  • Gastar Exploration Ltd. GST (2)
  • Gemini Explorations Inc. GXPI (12)
  • Gen2media Corp. GTWO (2)
  • General Environmental Management Inc. GEVI (56)
  • General Metals Inc. GNMT (1)
  • General Steel Holdings Inc. GSI (3)
  • GeoBio Energy Inc. GBOE (1)
  • GeoEye Inc. GEOY (4)
  • GeoPharma Inc GORX (1)
  • Giggles N’ Hugs Inc. GIGL (90)
  • Global Alumina Corp. GLA.U (1)
  • Global General Technologies Inc. GLGT (1)
  • Global Payout Inc. GOHE (38)
  • Global Realty Development Corp. GRLY (10)
  • Global Resource Corporation GBRC (48)
  • Global Roaming Distribution Inc. GRDB (34)
  • GlobalWise Investments Inc. GWIV (129)
  • GNCC Capital Inc. GNCP (24)
  • Golden West Brewing Company Inc. GWBC (3)
  • GoldSpring Inc. GSPG (4)
  • Google, Inc. GOOG (8)
  • GotStocks.net (1)
  • Grandview Gold Inc. GVGDF (2)
  • Gray Publishing & Media, Inc. GPMIJ (15)
  • Graystone Park Enterprises Inc. GPKE (7)
  • Great Plains Holdings Inc. GTPH (28)
  • Green Earth Technologies GETG (1)
  • Green Star Alternative Energy Inc. GSAE (2)
  • Green Star Products Inc. GSPI (2)
  • Green Technology Solutions Inc. (GTSO) (19)
  • Greenbelt Resources Corp. GRCO (1)
  • Greenchek Technology Inc. GCHK (18)
  • GreeneStone Healthcare Corp. GRST (3)
  • Greenstone Holdings Inc. GSHN (2)
  • GREM USA GRMU (2)
  • GRILLiT Inc. GRLT (8)
  • Growblox Sciences Inc. GBLX (24)
  • GT Legend Automotive Holdings Inc. GTLA (2)
  • GTX Corp GTXO (49)
  • Gulf Western Petroleum Corp. GWPC (3)
  • GWS Technologies Inc. GWSC (4)
  • Halcyon Jets Holdings Inc. HJHO (15)
  • Halitron Inc. HAON (11)
  • Hanover Financial Services (17)
  • Harbin Electric Inc. HRBN (2)
  • Harvey Electronics Inc. HRVE (1)
  • Hasco Medical Inc. HASC (7)
  • Hathway Corp. HWYI (1)
  • HeadsUp Entertainment International Inc. HDUP (3)
  • Healthnostics Inc. HNSO (1)
  • HealthSonix Inc. HSXI (1)
  • HealthSport Inc. HSPO (14)
  • Heartland Inc. HTLG (1)
  • Heartland Oil and Gas Corp. HTOG (7)
  • Hemis Corporation HMSO (19)
  • Hemisphere Gold Inc. HPGI (1)
  • Hemp Inc. HEMP (25)
  • Hendrx Corp. HDRX (1)
  • Hi-Shear Technology Corp. HSR (3)
  • HII Technologies Inc. HIIT (8)
  • Holloman Energy Corp. HENC (2)
  • Holmes Osborne (6)
  • Hologic Inc. HOLX (4)
  • Home Shopping Latino Inc. HSPG (8)
  • Hong Kong Highpower Technology Inc. HPJ (2)
  • HotOTC (61)
  • HotStockChat (3)
  • HotStockMarket (HSM) (3)
  • HST Global Inc. HSTC (11)
  • Hunt Gold Corp. HGLC (32)
  • HWI Global Inc. HWIC (3)
  • Hydrogen Corp. HYDG (1)
  • i-Level Media Group Inc. ILVL (3)
  • i2 Telecom International Inc. ITUI (7)
  • iB3 Networks Inc. IBNW (1)
  • IceWEB Inc. IWEB (5)
  • ICP Solar Technologies Inc. ICPR (3)
  • IDGLOBAL Corp. IDGJ (2)
  • IDO Security Inc. IDOI (22)
  • IFAN Financial Inc. IFAN (34)
  • iGambit, Inc. IGMB (5)
  • Imaging3 Inc. IMGG (2)
  • ImaRx Therapeutics Inc. IMRX (2)
  • Immune Therapeutics Inc. IMUN (11)
  • Impact E-Solutions Corp. IESO (1)
  • Imperial Petroleum Inc. IPMN (10)
  • Inca Designs Inc. IDGI.PK (4)
  • Independent Film Development Corp. IFLM (1)
  • Index Oil and Gas Inc. IXOG.OB (5)
  • India Globalization Capital Inc. IGC (4)
  • Industrial Biotechnology Corp. IBOT (1)
  • Infinite Group Inc. IMCI (48)
  • Inform Worldwide Holdings, Inc. IWWI (27)
  • Intec LTD ICLJY (1)
  • IntegraMed America Inc INMD (1)
  • Intelecom Inc. IECM (3)
  • Intelimax Media Inc. IXMD (31)
  • Intelligent Highway Solutions Inc. IHSI (6)
  • Intercept Energy Services Inc. IESCF (7)
  • Interleukin Genetics Inc. ILI (1)
  • International Barrier Technology Inc IBTGF (1)
  • International Consolidated Companies Inc. INCC (2)
  • International Stem Cell Corp. ISCO (226)
  • Inventergy Global Inc. INVT (15)
  • Investor Village (9)
  • Investors Business Daily (4)
  • InvestorsProfs (1)
  • InvestSource (11)
  • IPOs (8)
  • IR Biosciences Holdings Inc IRBS (3)
  • Isonics Corp. ISON (1)
  • ItsAboutFinance (2)
  • JC Data Solutions Inc. JCDS (4)
  • Joytoto USA Inc. JYTO (14)
  • JZZ Technologies Inc. JZZI (3)
  • KAL Energy Inc. KALG (3)
  • Kallo Inc. KALO (43)
  • Kandi Technologies Corp. KNDI (3)
  • KCM Holding Corp. KCMH (3)
  • Kingslake Energy Inc. KGLJ (2)
  • Klondex Mines Ltd. KLNDF (1)
  • Knobias KNBS (5)
  • Kraig Biocraft Laboratories Inc. KBLB (88)
  • L&L International Holdings Inc. LLFH (2)
  • Laguna Blends Inc. LAGBF (53)
  • Lantis Laser Inc. LLSR (5)
  • Last Mile Logistics Group LMLG (4)
  • Latitude 360 Inc. LATX (21)
  • LD Holdings Inc. LDHL (14)
  • Legacy Holdings Inc. LGYH (1)
  • Legacy Ventures International Inc. LGYV (24)
  • Legend Media Inc. LEGE (4)
  • Lifespan Inc. LSPN (1)
  • Lime Energy Corp. LIME (3)
  • Lingo Media Corp. LMDCF (18)
  • Linkwell Corporation LWLL (4)
  • Liquor Group Wholesale Inc. LIQR (22)
  • Loans4Less.com Inc. LFLS (47)
  • LOGIC Devices Inc. LOGC (1)
  • Logility Inc. LGTY (1)
  • LoJack Corp LOJN (3)
  • Longhai Steel Inc. LGHS (10)
  • Lotus Pharmaceuticals Inc. LTUS (1)
  • Low Carbon Technologies (LWCTF) (3)
  • Lucas Energy, Inc. LEI (17)
  • Mabwe Minerals Inc. MBMI (56)
  • Macquarie Infrastructure Company MIC (5)
  • Maine and Maritime Corp. MMA (1)
  • Majic Wheels Corp. MJWL (6)
  • Makeup Inc. MAKU (2)
  • Mammoth Energy Group Inc. MMTE (5)
  • Mantra Venture Group Ltd. MVTG (10)
  • Mariner’s Choice International Inc. MCII (2)
  • Martin Nutraceuticals MNIU (11)
  • Material Technologies Inc. MTCH (44)
  • Max Media Group Inc. MXMI (9)
  • Max Sound Corp. MAXD (30)
  • MC Endeavors Inc. MSMY (2)
  • MedeFile International Inc. MDFI (46)
  • MediaG3 Inc. MDGC (1)
  • Medical Transcription Billing Corp. MTBC (13)
  • Medina International Holdings Inc. MIHI (3)
  • Medisafe 1 Technologies Corp. MFTH (3)
  • Medivisor Inc. MVSR (1)
  • Mega Media Group, Inc. MMDA (30)
  • MegaWest Energy Corporation MGWSF (2)
  • Memry Corp. MRY (2)
  • Metro One Development Inc. MODI (2)
  • Mexico Energy Corp. MXC (1)
  • Micro Identification Technologies Inc. MMTC (44)
  • MicrocapMoney (2)
  • Microsoft Corporation MSFT (4)
  • Midway Gold Corp. MDW (1)
  • Military Resale Group MYRL (19)
  • Minco Silver Corp. MSV.TO (1)
  • Mindpix Corp. MNDP (1)
  • MIP Solutions Inc. MSOL (7)
  • MIT Holding MITD (36)
  • MitoPharm Corp. MTPH (1)
  • Mizati Luxury Alloy Wheels, Inc. MZTI (14)
  • Mobile Entertainment Inc. MBEI (1)
  • Mobile Lads Corp. MOBO (43)
  • Momentous Entertainment Group Inc. MMEG (19)
  • Monaker Group Inc. MKGI (47)
  • Money4Gold Holdings Inc. MFGD (3)
  • MortgageBrokers.com Holdings Inc. MBKR (2)
  • Mosquito Consolidated Gold Mines Limited MSQ.V (1)
  • Moxian Inc. MOXC (62)
  • mPhase Technologies Inc. XDSL (12)
  • MSE Enviro-Tech Corp. MEVT (4)
  • Muscle Flex Inc. MFLI (55)
  • MusclePharm Corp. MSLP (23)
  • Mvive Inc. MVIV (22)
  • My Automated Advisor (4)
  • MyECheck Inc. MYEC (99)
  • MyStaru.com Inc. MYST (1)
  • Nanogen Inc. NGEN (2)
  • Nanometrics Inc. NANO (1)
  • NanoSensors Inc. NNSR (1)
  • NanoTech Entertainment Inc. NTEK (30)
  • Napster, Inc. NAPS (5)
  • National Automation Services Inc. NASV (67)
  • National Coal Corp. NCOC (2)
  • National Waste Management Holdings Inc. NWMH (18)
  • Naturally Iowa Inc. NLIA (2)
  • NavStar Technologies Inc. NVSR (16)
  • nCoat Inc NCOA (8)
  • Neah Power Systems NPWZ (14)
  • Neohydro Technologies Corp. NHYT (4)
  • Neoprobe Corp. NEOP (6)
  • NeoStem Inc. NBS (6)
  • Net Element Inc. NETE (19)
  • NetSol Technologies Inc NTWK (64)
  • Neurobiological Technologies Inc. NTII (3)
  • NeuroMama Ltd. NERO (15)
  • Neutra Corp. NTRR (37)
  • New Asia Gold Corp. NWAG (1)
  • New Generation Biofuel Holdings Inc. GNB (3)
  • NewMarket China Inc. NMCH (7)
  • NewMarket Technology Inc. NMKT (7)
  • Newport Digital Technologies Inc. NPDT (61)
  • Nexia Holdings Inc. NXHD (51)
  • NexMed Inc. NEXM (8)
  • NeXplore Corp. NXPC (4)
  • Next One Interactive Inc. NXOI (7)
  • NextGen Bioscience Inc. NXGB (1)
  • NextPhase Wireless Inc. NPHS (1)
  • Nexus Enterprise Solutions Inc. NXES (30)
  • NF Energy Saving Corp. of America NFES (1)
  • Nhale Inc. NHLE (18)
  • Nilam Resources Inc. NILR (4)
  • Nitro Petroleum Inc. NTRO (5)
  • North Bay Resources Inc. NBRI (10)
  • NuTech Inc. NTCI (1)
  • Nutra Pharma Corp. NPHC (21)
  • NutraNomics Inc. NNRX (30)
  • NuVim Inc. NUVM (1)
  • NVIDIA Corp. NVDA (1)
  • NXGen Holdings Inc. NXGH (1)
  • Oakridge Global Energy Solutions Inc. OGES (63)
  • Obee's Franchise Systems Inc. OBFM (1)
  • OBJ Enterprises Inc. OBJE (27)
  • Odyne Corporation ODYC (15)
  • Omega Commercial Finance Corp. OCFN (2)
  • OmniaLuo Inc. OLUO (1)
  • Omnicity Corp. OMCY (26)
  • Omninet Media.Com, Inc. ONMC (5)
  • On The Go Healthcare Inc. MODI (13)
  • On the Move Systems Inc. OMVS (102)
  • Oncolin Therapeutics Inc. OCOL (1)
  • One World Holdings Inc. OWOO (61)
  • Ones to Watch (1,349)
  • Onstream Media Corp. ONSM (5)
  • Onteco Corp. ONTC (4)
  • Open Energy Corp. OEGY (4)
  • Optical Systems Inc. OPSY (2)
  • Oramed Pharmaceuticals Inc. ORMP (2)
  • Organic Alliance Inc. ORGC (2)
  • ORhub, Inc. ORHB (2)
  • OTCPicks.com (82)
  • OtcStockExchange (5)
  • OurPet's Company OPCO (78)
  • OxySure Systems Inc. OXYS (23)
  • P2 Solar Inc. PTOS (24)
  • Pacific Gold Corp. PCFG (3)
  • Pamplona Picks (1)
  • Pan Global Corp. PGLO (82)
  • PanGenex Corp. PGCX (3)
  • Paramount Gold and Silver Corp. PZG (3)
  • Patient Access Solutions Inc. PASO (7)
  • Patriot Energy Corp. dba TelTeck Solutions Inc PGYC.PK (11)
  • Patriot Scientific Corp. PTSC (6)
  • Peace Arch Entertainment Group Inc. PAE (1)
  • Peoples Educational Holdings Inc. PEDH (2)
  • Perf Go Green Holdings Inc. PGOG (12)
  • Perfect Web Technologies, Inc PWBI (11)
  • Perfectenergy International Ltd. PFGY (1)
  • Performance Health Technologies Inc. PFMH (31)
  • Pet DRX Corp. VETS (1)
  • Petro Resources Corp. PRC (2)
  • PetroSun Inc. PSUD (41)
  • Phantom Fiber Corp. PHFB (2)
  • Pilot Financial Communications (3)
  • Pipex Pharmaceuticals Inc. PP (2)
  • PITOOEY! Inc. PTOO (14)
  • Planet Nutrition Inc. PNHL (4)
  • Platina Energy Group Inc. PLTG (8)
  • PlayBOX Inc. PYBX (5)
  • Player's Network, Inc. PNTV (1)
  • Players Network PNTV (4)
  • Pluristem Therapeutics Inc. PSTI (10)
  • Positron Corp. POSC (3)
  • Power of the Dream Ventures (1)
  • Power Play Development Corp. PWPY (17)
  • Powersafe Technology Corp. PWSF (1)
  • Premier Energy Corp. PNRC (1)
  • Pressure BioSciences Inc. PBIO (41)
  • PRG Group Inc. PRGJ (2)
  • PrimEdge Inc. PEDI (1)
  • Private Equity Securities (93)
  • Pro Motors Group Corp. PMGU (2)
  • Pro Travel Network Inc. PTVL (2)
  • ProGaming Platforms Corp. PPTF (22)
  • Proginet Corp. PRGF (3)
  • Prom Resources PRMO (9)
  • Propalms Inc. PRPM (3)
  • Provectus Pharmaceuticals Inc. PVCT (12)
  • Puget Technologies Inc. PUGE (23)
  • Pulmo BioTech Inc. PLMO (4)
  • Puramed Bioscience Inc. PMBS (3)
  • Pure Biofuels Corp. PBOF (4)
  • Pure H2O Inc. PURH (1)
  • Pure Hospitality Solutions Inc. PNOW (99)
  • Purio Inc. PURO (5)
  • Puritan Financial Group Inc. PTNG (1)
  • Purple Beverage Company Inc. PPBV (8)
  • QED Connect Inc. QEDC (4)
  • Qiao Xing Universal Telephone Inc. XING (2)
  • QPC Lasers Inc. QPCI (3)
  • Qualcomm Inc. QCOM (2)
  • QualityStocks for Women (16)
  • QualityStocks Partner StockGuru (3,878)
  • QualityStocks Stock Newsletter (551)
  • QualityStocks Stock Newsletters (18,170)
  • QualityStocks Video Charts (286)
  • QualityStocks.net Market Basics (6)
  • Quantum Fuel Systems Technologies Worldwide Inc. QTWW (15)
  • Quantum International Corp. QUAN (3)
  • Quasar Aerospace Industries Inc. QASP (6)
  • QuoteMedia Inc. QMCI (120)
  • Rafarma Pharmaceuticals Inc. RAFA (31)
  • Rainbow Coral Corp. RBCC (33)
  • Rancher Energy Corp. RNCH (9)
  • Raptor Resources Holdings Inc. RRHI (50)
  • Raven Gold Corp. RVNG (3)
  • Red Lake Exploration Inc. RLKX (19)
  • RegalWorks Media Inc. RWMI (4)
  • Regenicin, Inc. RGIN (6)
  • Reliant Financial Services Inc. RFNS (1)
  • Renhuang Pharmaceuticals Inc. RHGP (3)
  • ReoStar Energy Corp. REOS (1)
  • Resort Savers Inc. (RSSV) (10)
  • Revett Minerals (1)
  • Rock Energy Resources Inc. RCKE (4)
  • Rodman & Renshaw (432)
  • Ronn Motor Company Inc. RNNM (6)
  • Rox Resources Ltd. RXRS (3)
  • Royal Quantum Group, Inc. RYQG (10)
  • Royal Standard Minerals Inc. RYSMF (2)
  • Rudy Nutrition RUNU (27)
  • RXi Pharmaceuticals Corp. RXII (3)
  • Santa Fe Gold Corp. SFEG (5)
  • Santa Fe Holding Company SFHD (3)
  • Save The World Air Inc. ZERO (12)
  • Savoy Energy Corp. SNVP (26)
  • SavWatt USA, Inc. SAVW (5)
  • Seabridge Gold Inc. SA (1)
  • Seawright Holdings Inc. SWRI (1)
  • Sector 10 Inc. SECI (78)
  • SES Solar Inc. SESI (2)
  • Seven Arts Pictures plc SAPX (1)
  • Seven Arts Pictures PLC SAPXF (5)
  • Shazam Stocks (22)
  • ShotPak Inc. SHTP (35)
  • Shumate Industries SHMTE (1)
  • Sibling Group Holdings Inc. SIBE (55)
  • Sierra Gold Corp. SGCP (2)
  • Signature Devices Inc. SDVI (9)
  • Silver Dragon Resources Inc. SDRG (1)
  • Silver Falcon Mining Inc. SFMI (1)
  • SilverSun Technologies Inc. SSNT (30)
  • Simtrol Inc. SMRL (74)
  • Simulated Environment Concepts Inc. SMEV (130)
  • Singlepoint Inc. SING (59)
  • Sino Agro Food Inc. SIAF (1)
  • Sinobiomed Inc. SOBM (4)
  • Sinovac Biotech Ltd SVC (1)
  • Sipp Industries Inc. SIPC (2)
  • Skinny Nutritional Corp. SKNY (19)
  • Sky Petroleum Inc. SKPI (1)
  • SkyPostal Networks Inc. SKPN (66)
  • Small Cap Sentinel (2)
  • Small Cap Sleeper (3)
  • Smallcap Bullets (2)
  • Smallcaps.us (22)
  • SmallCapVoice (428)
  • Smoky Market Foods Inc. SMKY (9)
  • SocialPicks (1)
  • Sofame Technologies Inc SDW.V (1)
  • Sohm Inc. SHMN (14)
  • Solanex Management Inc. SLNX (15)
  • Solar Energy Initiatives Inc. SNRY (14)
  • Solar Wind Energy Tower Inc. SWET (15)
  • Solarfun Power Holdings Co. Ltd. SOLF (2)
  • Soul and Vibe Interactive Inc. SOUL (14)
  • South Sea Energy Corp. SSGY (7)
  • Soyo Group Inc SOYO (2)
  • SpaceDev Inc. SPDV (5)
  • Sparta Commercial Services Inc. SRCO (31)
  • Speedemissions Inc. SPMI (14)
  • Spicy Pickle Inc SPKL (18)
  • SpongeTech Delivery Systems Inc. SPNG (14)
  • Sports Pouch Beverage Company Inc. SPBV (1)
  • Star Mountain Resources Inc. SMRS (37)
  • Start Scientific Inc. STSC (22)
  • Stealth Technologies, Inc. STTH (2)
  • Stock Market E-News (1)
  • Stock Promoters (4)
  • StockEgg (14)
  • Stocks to Watch (1,846)
  • StocksJournal (2)
  • StockUPTicks (165)
  • Stockwire (6)
  • Strategic American Oil Corp SGCA (32)
  • Stratos Renewables Corp. SRNW (89)
  • StreamTrack Inc. STTK (31)
  • Striker Oil & Gas Inc. SOIS (4)
  • Sun Motor International Inc. SNMO (1)
  • SUN Sports & Entertainment Inc. SSPE (3)
  • Sunshine Biopharma Inc. SBFM (6)
  • Superlattice Power Inc. SLAT (60)
  • SupportSave Solutions, Inc. SSVE (10)
  • Surefect Holdings Inc. SUFH (1)
  • Suspect Detection Systems Inc. SDSS (37)
  • Sweet Success Enterprises Inc. SWTS (35)
  • Swiss Hawk AG SWHKF (1)
  • Symposium Production Corp. SYPJ (1)
  • Tactical Air Defense Services, Inc. TADF (15)
  • Tao Minerals Ltd. TAOL (1)
  • TapImmune Inc. TPIV (14)
  • Taplmmune Inc. TPIM (1)
  • Technology Applications International Inc. NUUU (25)
  • TechPrecision Corp. TPCS (4)
  • Tecton Corp. TTNC (3)
  • Teknik Digital Arts Inc. TKNK (10)
  • Telanetix Inc. TNXI (2)
  • Teletouch Communications Inc. TLLE (5)
  • Terax Energy Inc. TEXG (32)
  • Terme Bancorp TMEB (1)
  • Terra Nostra Resources Corp. TNRO (25)
  • The Amergence Group AMNG (8)
  • The Aristocrat Group Corp. ASCC (113)
  • The Bowser Report (68)
  • The Bull Report (32)
  • The Capital Report (5)
  • The DIRECTV Group Inc. DTV (1)
  • The Fight Zone Inc. TFZI (12)
  • The Guitammer Company Inc. GTMM (38)
  • The International Traders Expo (30)
  • The Mobile Star Corp. MBST (7)
  • The Motley Fool (3)
  • The Mundus Group Inc. MNDS (1)
  • The Penny Stock Blog (28)
  • The Principal Structure Fund, Inc. PSF (2)
  • The Tracking Corp. TRKG (1)
  • The UpTurn, Inc. UPTR (20)
  • The Wall Street Savant (24)
  • The Wide Angle (3)
  • Thresher Industries Inc. THRR (15)
  • Tidelands Oil and Gas Corp. TIDE (1)
  • Tiens Biotech Group USA Inc. TBV (1)
  • TMT Capital Corp. TMTP (1)
  • TNI BioTech Inc. TNIB (16)
  • Tombstone Exploration Corp. TMBXF (9)
  • TOMI Environmental Solutions Inc. TOMZ (4)
  • Tootie Pie Company, Inc. TOOT (11)
  • Torchlight Energy Resources, Inc. TRCH (2)
  • TradeShow Marketing Company Inc. TSHO (21)
  • TransWorldNews (4)
  • Tri-Star Holdings Inc. TSHL (31)
  • Trimax Corp. TMXN (31)
  • TripleCrownStocks (9)
  • True 2 Beauty Inc. TRTB (43)
  • TwinTrader (8)
  • TXP Corporation TXPO (1)
  • TZ Ltd. TZL.AX (1)
  • U.S. Mine Makers Inc. USMM (1)
  • uKarma Corporation UKMA (1)
  • Ultitek Ltd. UITK (21)
  • Unbridled Energy Corporation TSX-UNE (21)
  • Unico Inc. UNCO (3)
  • Universal Bioenergy Inc. UBRG (3)
  • Universal Detection Technology UNDT (41)
  • Universal Energy Corp. UVSE (19)
  • Universal Property Development and Acquisition UPDA (4)
  • Universal Tracking Solutions Inc. UTRK (13)
  • Universal Travel Group UTVG (14)
  • UpSNAP Inc. UPSN (1)
  • Uranium Energy Corp. UEC (64)
  • Uranium Hunter Corp. URHN (17)
  • Urex Energy Corp. URXE (1)
  • USA Recycling Industries Inc. USRI (21)
  • USA Superior Energy Inc. USSU (9)
  • Ustelematics Inc. UTLM (27)
  • Utah Uranium Corp. UTUC (2)
  • Utilicraft Aerospace Industries Inc. UITA (2)
  • ValueRich & iValueRich (9)
  • Vaporin Inc. VAPOD (2)
  • VentriPoint Diagnostics Ltd. VPTDF (26)
  • Vermillion Inc. VRML (3)
  • Vertical Branding Inc. VBDG (11)
  • VIASPACE, Inc. VSPC (185)
  • Victory Energy Corp. VYEY (29)
  • Vidshadow Inc. VSHD (1)
  • View Systems Inc. VSYM (16)
  • Viper Networks Inc. VPER (2)
  • Viral Genetics Inc. VRAL (3)
  • Viropro International Inc. VPRO (2)
  • VirTra Systems Inc. VTSI (22)
  • Viscount Systems Inc. VSYS (27)
  • visionGATEWAY Inc. VGWA (1)
  • VistaGen Therapeutics Inc. VSTA (104)
  • Visualant Inc. VSUL (5)
  • Vital Products Inc. VTLP (5)
  • Viyya Technologies Inc. VYON (2)
  • VizStar Inc VIZS (24)
  • Voiceserve Inc. VSRV (18)
  • Vortex Resources Corp. VTEX (7)
  • Vsurance Inc. VSUR (3)
  • Vyteris Inc. VYHN (1)
  • W2 Energy Inc. WWEN (13)
  • Wall Street News Alert (76)
  • WallStreetGrapevine (12)
  • WaterPure International Inc. WPUR (4)
  • Wave Systems Corp. WAVX (5)
  • Week in Review (2)
  • Well Power Inc. WPWR (77)
  • Wescorp Energy Inc. WSCE (18)
  • West Canyon Energy Corp. WCYO (1)
  • Western Standard Energy Corp. WSEG (7)
  • Who's Your Daddy Inc. WYDI (7)
  • WikiLoan Inc. WKLI (14)
  • Wind Energy America Inc. WNEA (3)
  • Wisdom Homes of America Inc. WOFA (15)
  • Wits Basin Precious Minerals Inc. WITM (2)
  • Woize International Ltd. WOIZ (1)
  • WordLogic Corp. WLGC (40)
  • Workstream Inc. WSTM (9)
  • WorldWater & Solar Technologies Corp. WWAT (10)
  • Worldwide Energy and Manufacturing WEMU (12)
  • Worldwide Manufacturing USA Inc. WWMU (6)
  • WRIT Media Group Inc. WRIT (36)
  • X-Change Corp. (XCHC) (2)
  • Xaar Plc XAARF (1)
  • Xenomics Inc. XNOM (1)
  • XsunX Inc. XSNX (17)
  • XZERES Corp. XPWR (2)
  • Younger America YNGR (13)
  • Zacks Investment Research (11)
  • ZAGG Inc. ZAGG (9)
  • Zaldiva Inc. ZLDV (3)
  • ZAP ZAAP (15)
  • ZBB Energy Corp ZBB (7)
  • Zenosense Inc. ZENO (53)
  • Zentric Inc. ZNTR (14)
  • Zevotek Inc. ZVTK (8)
  • Znomics Inc. ZNOM (3)
  • Newsletter Signup

    Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

    Rotate your device 90° to view site.